393 related articles for article (PubMed ID: 24092877)
1. Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1) in mice and zebrafish.
Valvezan AJ; Huang J; Lengner CJ; Pack M; Klein PS
Dis Model Mech; 2014 Jan; 7(1):63-71. PubMed ID: 24092877
[TBL] [Abstract][Full Text] [Related]
2. Adenomatous polyposis coli (APC) regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3) activity.
Valvezan AJ; Zhang F; Diehl JA; Klein PS
J Biol Chem; 2012 Feb; 287(6):3823-32. PubMed ID: 22184111
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice.
Fujishita T; Aoki K; Lane HA; Aoki M; Taketo MM
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13544-9. PubMed ID: 18768809
[TBL] [Abstract][Full Text] [Related]
4. mTORC1-mediated translational elongation limits intestinal tumour initiation and growth.
Faller WJ; Jackson TJ; Knight JR; Ridgway RA; Jamieson T; Karim SA; Jones C; Radulescu S; Huels DJ; Myant KB; Dudek KM; Casey HA; Scopelliti A; Cordero JB; Vidal M; Pende M; Ryazanov AG; Sonenberg N; Meyuhas O; Hall MN; Bushell M; Willis AE; Sansom OJ
Nature; 2015 Jan; 517(7535):497-500. PubMed ID: 25383520
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.
Hardiman KM; Liu J; Feng Y; Greenson JK; Fearon ER
PLoS One; 2014; 9(4):e96023. PubMed ID: 24763434
[TBL] [Abstract][Full Text] [Related]
6. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development.
Shelton DN; Sandoval IT; Eisinger A; Chidester S; Ratnayake A; Ireland CM; Jones DA
Cancer Res; 2006 Aug; 66(15):7571-7. PubMed ID: 16885356
[TBL] [Abstract][Full Text] [Related]
8. The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15.
Huang X; Langelotz C; Hetfeld-Pechoc BK; Schwenk W; Dubiel W
J Mol Biol; 2009 Aug; 391(4):691-702. PubMed ID: 19576224
[TBL] [Abstract][Full Text] [Related]
9. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
[TBL] [Abstract][Full Text] [Related]
10. Testing models of the APC tumor suppressor/β-catenin interaction reshapes our view of the destruction complex in Wnt signaling.
Yamulla RJ; Kane EG; Moody AE; Politi KA; Lock NE; Foley AV; Roberts DM
Genetics; 2014 Aug; 197(4):1285-302. PubMed ID: 24931405
[TBL] [Abstract][Full Text] [Related]
11. USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating β-Catenin Deubiquitination.
Novellasdemunt L; Foglizzo V; Cuadrado L; Antas P; Kucharska A; Encheva V; Snijders AP; Li VSW
Cell Rep; 2017 Oct; 21(3):612-627. PubMed ID: 29045831
[TBL] [Abstract][Full Text] [Related]
12. Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC-binding proteins, is a positive regulator of Wnt-β-catenin signalling.
Brauburger K; Akyildiz S; Ruppert JG; Graeb M; Bernkopf DB; Hadjihannas MV; Behrens J
FEBS J; 2014 Feb; 281(3):787-801. PubMed ID: 24251807
[TBL] [Abstract][Full Text] [Related]
13. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
[TBL] [Abstract][Full Text] [Related]
14. A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression.
Zeineldin M; Cunningham J; McGuinness W; Alltizer P; Cowley B; Blanchat B; Xu W; Pinson D; Neufeld KL
Oncogene; 2012 May; 31(19):2423-37. PubMed ID: 21996741
[TBL] [Abstract][Full Text] [Related]
15. Identification of Endogenous Adenomatous Polyposis Coli Interaction Partners and β-Catenin-Independent Targets by Proteomics.
Popow O; Paulo JA; Tatham MH; Volk MS; Rojas-Fernandez A; Loyer N; Newton IP; Januschke J; Haigis KM; Näthke I
Mol Cancer Res; 2019 Sep; 17(9):1828-1841. PubMed ID: 31160382
[No Abstract] [Full Text] [Related]
16. Induction of endoplasmic reticulum stress by deletion of Grp78 depletes Apc mutant intestinal epithelial stem cells.
van Lidth de Jeude JF; Meijer BJ; Wielenga MCB; Spaan CN; Baan B; Rosekrans SL; Meisner S; Shen YH; Lee AS; Paton JC; Paton AW; Muncan V; van den Brink GR; Heijmans J
Oncogene; 2017 Jun; 36(24):3397-3405. PubMed ID: 27819675
[TBL] [Abstract][Full Text] [Related]
17. When You Come to a Fork in the Road, Take It: Wnt Signaling Activates Multiple Pathways through the APC/Axin/GSK-3 Complex.
Li C; Furth EE; Rustgi AK; Klein PS
Cells; 2023 Sep; 12(18):. PubMed ID: 37759479
[TBL] [Abstract][Full Text] [Related]
18. Reversible modification of adenomatous polyposis coli (APC) with K63-linked polyubiquitin regulates the assembly and activity of the β-catenin destruction complex.
Tran H; Polakis P
J Biol Chem; 2012 Aug; 287(34):28552-63. PubMed ID: 22761442
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous inactivation of tsc2 enhances tumorigenesis in p53 mutant zebrafish.
Kim SH; Kowalski ML; Carson RP; Bridges LR; Ess KC
Dis Model Mech; 2013 Jul; 6(4):925-33. PubMed ID: 23580196
[TBL] [Abstract][Full Text] [Related]
20. The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells.
Yedid N; Kalma Y; Malcov M; Amit A; Kariv R; Caspi M; Rosin-Arbesfeld R; Ben-Yosef D
BMC Cancer; 2016 Dec; 16(1):952. PubMed ID: 28010732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
